Page last updated: 2024-10-30

lg 100268 and Alloxan Diabetes

lg 100268 has been researched along with Alloxan Diabetes in 2 studies

LG 100268: a retinoid X receptor (RXR) selective compound; structure given in first source

Research Excerpts

ExcerptRelevanceReference
" To determine whether rexinoids lower hyperglycemia by activating the RXR/PPAR-gamma heterodimer in vivo, we compared the effects of a rexinoid (LG100268) and a TZD (rosiglitazone) on gene expression in white adipose tissue, skeletal muscle, and liver of Zucker diabetic fatty rats (ZDFs)."3.71Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. ( Boehm, M; Crombie, DL; Davies, PJ; Depre, C; Heyman, RA; Leibowitz, MD; Liu, S; Nagy, L; Singh Ahuja, H; Tontonoz, P, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singh Ahuja, H1
Liu, S1
Crombie, DL1
Boehm, M1
Leibowitz, MD2
Heyman, RA1
Depre, C1
Nagy, L1
Tontonoz, P1
Davies, PJ2
Shen, Q1
Cline, GW1
Shulman, GI1

Other Studies

2 other studies available for lg 100268 and Alloxan Diabetes

ArticleYear
Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.
    Molecular pharmacology, 2001, Volume: 59, Issue:4

    Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease

2001
Effects of rexinoids on glucose transport and insulin-mediated signaling in skeletal muscles of diabetic (db/db) mice.
    The Journal of biological chemistry, 2004, May-07, Volume: 279, Issue:19

    Topics: Acyl Coenzyme A; Animals; Anticholesteremic Agents; Biological Transport; Blotting, Western; Body We

2004